You are on page 1of 32

Trade Name: Cipro

Classification: Broad-Spectrum Antiinfectives
Use(s): Infections caused by susceptible organisms E. Coli,
Proteus, staph.
Action: Interferes with conversion of DNA fragments into
higher molecular weight ones. DNA gyrase inhibitors.
Contraindications: Hypersensitivity to quinolones
Side Effects: Headache, dizziness, restlessness, N/V/D.
Nursing implications: Assess for CNS symptoms, I&O
ratio, allergic reactions.

CLASSIFICATION: Antianemic, iron
ACTION: Normal daily intake males 12-20 mg; females 8-15 mg;
only 10% absorbed; Iron absorbed by from duodenum and upper
jejunum by active mechanism thru mucosal cells, combines with
transferring; iron stored as hemosiderin or aggregated ferritin cells
of liver, spleen, bone marrow; 2/3 of iron in circulating RBC’s
INDICATIONS: Prophylaxis, treatment of iron deficiency and irondeficiency anemia’s; dietary supplement for iron
USUAL DOSAGE: Adults 300 mg/day
ADVERSE REACTIONS: Constipation, gastric irritation, nausea,
abdominal cramps, anorexia, diarrhea, dark-colored stools
NURSING CONSIDERATIONS: Substitution of one iron salt for
another without proper adjustment may result in serious over or

under dosing; Eggs, milk, coffee or tea may significantly inhibit iron

CLASSIFICATION: Antibiotic, penicillin
ACTION: Synthetic broad-spectrum penicillin closely related to
ampicillin; Binds to bacterial cell wall (PBP-1 and PBP-3; penicillinbinding sites), causing cell death by inhibiting cell wall synthesis;
bactericidal action; spectrum is larger than penicillin’s
INDICATIONS: Ear, nose, and throat infections.
Over 40 kg: 500 mg q8hr or 500 mg q12hr; under 40 kg:
20mg/kg/day in divided doses q8hr
ADVERSE REACTIONS: Hypersensitivity, nausea & vomiting,
gastritis, stomatitis.

and purulent or septic arthritis. lactation NURSING CONSIDERATIONS: IV injections usually diluted with IV solution. report unusual symptoms. meningitis. take full dosage. Assess for allergic reactions (if reaction occurs. stop drug immediately). bacteremia. ACETAMINOPHEN CLASSIFICATION: non-narcotic analgesic . pericarditis. PO use of PCNs during acute stages of emphysema. monitor vitals.CONTRAINDICATIONS: Hypersensitivity to PCNs. should be prescribed cautiously to nursing mothers. pneumonia. assess for 20 min after administering to check for allergies.

hydantoins. rifampin & sulfinpyrazone: ↑ hepatotoxicity potential related to ↑ liver breakdown. May cause analgesia by inhibiting CNS prostaglandin synthesis. acetaminophen has no antiinflammatory or uricosuric effects. GI upset in some. due to minimal effects on peripheral prostaglandin synthesis. . however. carbamazepine. Antipyretic and analgesic effects are comparable to those of aspirin.ACTION: Decreases fever by 1) a hypothalamic effect leading to sweating and vasodilation and 2) inhibits the effect of pyrogens on the hypothalamic heat-regulating centers. barbiturates. Does not cause any anticoagulant effect or ulceration of the GI tract. isoniazid. Chronic and even acute toxicity can develop after long symptom-free usage INTERACTIONS: Chronic EtOH ↑ toxicity of larger therapeutic doses. INDICATIONS: 1) Control of pain 2) Reduces fever in bacterial or viral infections USUAL DOSAGE: Adults: 325-650 mg q4hr ADVERSE REACTIONS: Few when taken in usual therapeutic doses.

HYDROCHLOROTHIAZIDE CLASSIFICATION: Antihypertensive. chloride. in clients requiring a diuretic and in whom hypokalemia cannot be risked. flatulence. Hydrochlorothiazide promotes excretion of sodium and chloride and thus water by distal renal tubule. and fluid. anorexia. dizziness. GI upset. Antihypertensive effects due to direct dilation of arterioles as well as fluid volume loss INDICATIONS: Hypertension or edema in clients who manifest hypokalemia on hydrochlorothiazide alone. combination drug ACTION: acts directly on the distal tubule to promote the excretion of sodium. Increases urinary pH. headache. photosensitivity . Also increases excretion of potassium and smaller amounts of bicarbonate. bicarbonate. diarrhea. usually not first line of therapy except when avoiding hypokalemia ADVERSE REACTIONS: Nausea & vomiting.

neck and prostate. especially cimetidine or Coumadin. monitor vital signs and tests (reduce dose with dysfunction. chest pain NURSING CONSIDERATIONS: identify drugs prescribed to ensure none of the drugs interact. pharyngitis/rhinitis. drug is taken to lower BP and reduce swelling of extremities (take in AM with food to reduce GI upset. urine flow rate is improved and there is a decrease in symptoms of BPH INDICATIONS: Signs and symptoms of BPH. shoulder/neck/back/extremity pain. asthenia. monitor CBC. rule-out prostatic carcinoma before using tamsulosin ADVERSE REACTIONS: Headache. diarrhea.NURSING CONSIDERATIONS: Assess for alcoholism. rash. dizziness. fever) TAMULOSIN HYDROCHLORIDE CLASSIFICATION: Alpha-adrenergic blocking drug ACTION: Blockade of alpha1-receptors (probably alpha1a) in the prostateresults in relaxation of smooth muscles in the bladder.thus. .

atenolol selectively blocks beta1adrenergic receptors located chiefly in cardiac muscle. note PSA levels. dizziness NURSING CONSIDERATIONS: Check apical pulse before giving oral drug. results of digital rectal exam. take as directed. do not chew. ADVERSE REACTIONS: Constipation. weight. Monitor apical pulse. If below 60 bpm (or other ordered parameter). urodynamic studies. or open capsule. withhold dose and consult physician. It is also used to treat angina and chest pain. indigestion. VS. and . INDICATIONS used to treat high blood pressure. BP. respirations. crush. dry mouth. especially in patients receiving digitalis (both drugs slow AV conduction). Atenolol (Tenormin) CLASSIFICATION: Beta-Blocker ACTION: In therapeutic doses.I&O.

peripheral circulation throughout dosage adjustment period. dizziness. ADVERSE REACTIONS:. which decreases vasopressor activity and aldosterone secretion. fatigue. ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITOR. Therefore. ACE catalyzes the conversion of angiotensin I to angiotensin II. Consult physician for acceptable parameters. INDICATIONS Management of mild to moderate hypertension. ENALAPRIL MALEATE (Vasotec) CLASSIFICATION: CARDIOVASCULAR AGENT. Hypotension. a vasoconstrictor substance. Headache. . inhibition of ACE decreases angiotensin II levels. ANTIHYPERTENSIVE ACTION: Angiotensin-converting enzyme (ACE) inhibitor.

abdominal pain. PROTON PUMP INHIBITOR ACTION Gastric acid pump inhibitor. Gastric acid secretion is decreased by inhibiting the H+. flatulence. ADVERSE REACTIONS: Diarrhea. . Older adults are particularly sensitive to drug-induced hypotension. belongs to a class of antisecretory compounds. INDICATIONS Short-term treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD).7 mEq/L). If antihypertensive effect is diminished before 24 h.NURSING CONSIDERATIONS: Monitor BP for first several days of therapy. Report transient hypotension with lightheadedness. Supervise ambulation until BP has stabilized. the total dose may be given as 2 divided doses. PANTOPRAZOLE CLASSIFICATION: GASTROINTESTINAL AGENT. K+ATPase enzyme system responsible for acid production. Lab tests: Monitor serum potassium and be alert to symptoms of hyperkalemia (K+ >5.

NSAID ACTION: Although its exact mechanism of action has not been fully elucidated. INDICATIONS Analgesic and antipyretic effects in symptomatic treatment of rheumatoid arthritis. it appears to be a potent inhibitor of cyclooxygenase. thereby decreasing the synthesis of prostaglandins. ANTIPYRETIC. Also acute gout. ANALGESIC. Lab tests: Urea breath test 4–6 wk after completion of therapy.NURSING CONSIDERATIONS: Monitor for and immediately report S&S of angioedema or a severe skin reaction. and ankylosing spondylitis. DICLOFENAC SODIUM CLASSIFICATION: CENTRAL NERVOUS SYSTEM AGENT. . osteoarthritis.

serum uric acid concentrations Hct. Up to 3 wks may be needed for beneficial effects with rheumatoid arthritis or osteoarthritis. abdominal pain. headache. bloody or black stools. drowsiness. petechiae. and blood glucose.ADVERSE REACTIONS:. ecchymoses. bleeding gums.g. . cloudy or bloody urine).. Observe and report signs of bleeding (e. Monitor BP for hypertension and blood sugar for hyperglycemia. Dizziness. vomiting. cramps NURSING CONSIDERATIONS: Monitor for therapeutic effectiveness. Lab tests: Periodic liver function. PT/INR.

prognosis. Risk for Fluid Volume Deficit related to: excessive evaporation and vomiting 5.1. and treatment needs related to: lack of sources of information. urgency and hesitancy 4. Impaired Urinary Elimination related to: frequent urination. Hyperthermia related to: inflammatory reaction 3. Knowledge Deficit: about condition. Acute pain related to: inflammation and infection of the urethra. 6. . Disturbed Sleep Pattern related to: pain and nocturia. 2. bladder and other urinary tract structures.

Rational: provides information about renal function and presence of complications 2) Determine the patient's voiding patterns 3) Encourage increased fluid intake Rationale: increased hydration will flush the bacteria. behavior or level of consciousness Rational: the accumulation of residual uremic and electrolyte imbalance can be toxic to the central nervous system 6) Unless contraindicated: reposition the patient every two hours Rational: To prevent static urine .1) Monitor input and output characteristics of the urine. 4) Review the full bladder complaints Rational: urinary retention may occur causing tissue distension (bladder / kidney) 5) Observations of changes in mental status:.

Occurs due to formation of a complex with antithrombin III and causing a conformational change in antithrombin III molecule. erythema. in low doses to prevent DVT and PE in pregnant clients with thromboembolism history and others. Action of thrombin in coagulation is inhibited. urticaria. but forestalls enlargement and prevents new clots from forming. fever. Potentiates inhibitory action of antithrombin III.7) Collaboration: . local irritation. hematoma INTERACTIONS: Oralanticoagulants/dipyridamole/hydroxychloroquine/ibuprofen/indomethacin/NSAIDs/ticlopidine – . chills. mild pain. Prophylaxis and treatment of venous thrombosis and extensions. Prophylaxis of clotting in blood transfusions and others ADVERSE REACTIONS: Hemorrhage ranging from minor local ecchymoses to major hemorrhagic complications from any organ. Atrial fibrillation with embolization. creatinine Rational: control of renal dysfunction HEPARIN CLASSIFICATION: Heparin. Anticoagulant ACTION: Does not dissolve previously formed clots.Monitor laboratory tests: electrolytes. Treatment and diagnosis of DIC. Also prevents formation of a stable fibrin clot by inhibiting the activation of fibrin-stabilizing factor by thrombin INDICATIONS: Pulmonary/peripheral arterial embolism.

brain or spinal cord or during continuous tube drainage of stomach or small intestine NURSING CONSIDERATIONS: Do not administer IM. do not massage site.additive ↑ prothrombin time. do not administer during surgery of eye. hematoma. thrombocytopenia. blood dyscrasias (or other bleedingdisorders as in hemophilia). perform test dose (1.000 units subQ) on clients with allergies or asthma history GENERIC NAME: METOPROLOL TARTRATE CLASSIFICATION: Beta-adrenergic Blocking Agent ACTION: Combines reversibly mainly with beta-adrenergic receptors to block the response to sympathetic nerve impulses. purpura. Antihistamines/digitalis/nicotine/nitroglycerin/tetracyclines . Blockage of betareceptors decreases heart rate. utilize Z-track method or ‘Bunch technique’ method.↓ effect of heparin CONTRAINDICATIONS: Active bleeding. administer by deep subQ injection to minimize local irritation. clients with frail or weakened blood vessels. all of which decreases blood pressure . circulating catecholamines. liver disease with hypoprothrombinemia. extensive denudation of skin. do not administer within 2in of umbilicus (decreased vascularity). or adrenergic drugs. slight discoloration does not affect potency. increased capillary permeability. myocardial contractility. and tissue sloughing and to prolong drug action. and cardiac output and slows AV conduction. open wounds.

diarrhea CONTRAINDICATIONS: MI in clients with a heart rate of less than 45 bpm. reduce dose. metaproterenol. do not increase dose until symptoms of worsening CHF have been stabilized. indicated in management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with mild/moderate/severe chronic renal failure not yet on dialysis. Acute MI in hemodynamically stable patients. do not stop suddenly Vitamin D INDICATIONS: management of hypocalcemia and resultant metabolic bone disease in patients undergoing chronic renal dialysis. treat with increased doses of diuretics. for CHF. if transcient worsening of heart failure occurs. moderate to severe cardiac failure NURSING CONSIDERATIONS: Do not confuse metoprolol with metoclopramide.INDICATIONS: Hypertension. or misoprostol. in second. or if SBP is less than 100 mm Hg.or third-degree heartblock. management of hypocalcemia and clinical manifestations in patients with postsurgical hypoparathyroidism. may need to lower dose of metoprolol or temporarily discontinue. if CHF clients experience symptomatic bradycardia. shortness of breath. Angina pectoris ADVERSE REACTIONS: Fatigue. and pseudohypoparathyroidism . dizziness. take dose each day at same time. idiopathichypoparathyroidism. bradycardia. depression.

elevated BUN. anti-inflammatory drug. photophobia. pruritis. dry mouth. headache. resulting in heat loss by vasodilation of peripheral blood vessels and promoting . use in patients with known hypersensitivity to Rocaltrol (or drugs of same class) or any of the inactive ingredients is contraindicated NURSING CONSIDERATIONS: Effectiveness is predicated on the assumption that each patient is receiving an adequate daily intake of calcium. nocturia. constipation. bone pain. weakness. elevated SGOT (AST) and SGPT (ALT) and MANY MORE CONTRAINDICATIONS: Should not be taken to patients with hypercalcemia or evidence of Vit D toxicity. patients should be advised of compliance with dosage instructions and adherence to instructions about diet and calcium supplementation. antipyretic ACTION: Exhibits antipyretic. muscle pain.ADVERSE REACTIONS: Hypercalcemia syndrome or calcium intoxication. analgesic. stomach pain. rhinorrhea. ASA) CLASSIFICATION: Nonsteroidal. and analgesic effects. somnolence. decreased libido. hyperthermia. advise avoidance of the use of unapproved nonprescription drugs. abdominal pain. calcific conjunctivitis. Antipyretic due to an action on the hypothalamus. anorexia. anti-inflammatory. polyuria. polydipsia. metallic taste. albuminuria. carefully inform about S&S of hypercalcemia GENERIC NAME: ASPIRIN (ACETYLSALICYCLIC ACID. N&V. hypercholesterolemia. advise patients to have dietary intake minimum of 600 mg daily. pancreatitis.

acute rheumatic fever. Biguanide . note if asthma. which results in a decrease in prostaglandin synthesis and other mediators of pain response INDICATIONS: Analgesic – Pain from integumentary structures. SLE. gout. administer with meals and glass of water GENERIC NAME: METFORMIN HYDROCHLORIDE CLASSIFICATION: Oral Antidiabetic. gout. hay fever. and many other conditions ADVERSE REACTIONS: Dyspepsia. history of blood coagulation defects. myalgias. Anti-inflammatory mediated through inhibition of cyclo-oxygenase. vitamin K deficiency NURSING CONSIDERATIONS : Enteric-coated or buffered tablets better tolerated by some. or nasal polyps have higher incidence of hypersensitivity. headache.sweating.arthralgias. dysmenorrheal. osteoarthritis. discomfort CONTRAINDICATIONS: Hypersensitivity to salicylates. take temperature 1 hour after administering. use epinephrine to counteract hypersensitivity. and similar types of pain. in conjunction with anticoagulant therapy. ulcer disease or nasal polyps. take with full glass of water. hay fever. neuralgias. epigastric. Antipyretic. take as directed. nausea. severe anemia. clients with asthma. Anti-inflammatory – arthritis.

decreases intestinal absorption of glucose. to improve glycemic control in clients with type 2 diabetes. as adjunct to diet and exercise. does not cause hypoglycemia in either diabetic or non diabetic clients. do not confuse Glucophage with Glucovance. may cause a metallic taste (will subside) GENERIC NAME: Candesartan . abdominal pain/discomfort NURSING CONSIDERATIONS: Lactic acidosis is a rare. individualize dosage based on tolerance and effectiveness. insulin secretion remains unchanged. increases peripheral uptake and utilization of glucose. diarrhea. Extended Release form used to treat type 2 diabetes as initial therapy or in conjunction with a sulfonylurea or insulin in clients 17 y/o and older ADVERSE REACTIONS: Lactic acidosis. while fasting insulin levels and day-long plasma insulin response may decrease INDICATIONS: As monotherapy. asthenia. headache. metabolic complication that can occur due to metformin accumulation (50 % fatal). may safely switch from metformin to metformin extended-release. flatulence. but serious. hypoglycemia. Immediate-release tablets and PO solution can be used in clients 10 yrs and older. give with meals and start at a low dose with gradual escalation (will reduce GI side effects).ACTION: Decreases hepatic glucose production. nausea & vomiting. and does not cause hyperinsulinemia.

and CBC with differential. dizziness. This helps to lower blood pressure. Candesartan selectively blocks binding of angiotensin II to the AT1 receptors found in many tissues (e. place in supine position and notify physician. serum potassium.. Angiotensin II is a potent vasoconstrictor and primary vasoactive hormone of the renin–angiotensin–aldosterone system. just prior to the next scheduled dose. vascular smooth muscle. It is used in certain patients to treat heart failure. should be made when possible. It may also be used for other conditions as determined by your doctor. trough readings. back pain.g. liver enzymes. It works by relaxing blood vessels. Monitor for transient hypotension in volume/salt-depleted patients. Candesartan is an angiotensin II receptor blocker (ARB). ADVERSE REACTIONS: upper respiratory tract infection. adrenal glands).CLASSIFICATION: ARB ACTION: Angiotensin II receptor (type AT1) antagonist. . and rhinitis NURSING CONSIDERATIONS: Monitor BP as therapeutic effectiveness is indicated by decreases in systolic and diastolic BP within 2 wk with maximal effect at 4–6 wk. pharyngitis. Monitor BP periodically. Lab tests: Periodically monitor BUN and creatinine. if hypotension occurs. INDICATIONS Treating high blood pressure alone or with other medicines.

It may also be used for other conditions as determined by your doctor. trough readings. Candesartan is an angiotensin II receptor blocker (ARB). ADVERSE REACTIONS: upper respiratory tract infection. should be made when . place in supine position and notify physician. back pain. just prior to the next scheduled dose. This helps to lower blood pressure. It works by relaxing blood vessels. Monitor BP periodically. and rhinitis NURSING CONSIDERATIONS: Monitor BP as therapeutic effectiveness is indicated by decreases in systolic and diastolic BP within 2 wk with maximal effect at 4–6 wk.g. vascular smooth muscle. Angiotensin II is a potent vasoconstrictor and primary vasoactive hormone of the renin–angiotensin–aldosterone system. It is used in certain patients to treat heart failure. pharyngitis. dizziness. Candesartan selectively blocks binding of angiotensin II to the AT1 receptors found in many tissues (e.GENERIC NAME: Candesartan CLASSIFICATION: ARB ACTION: Angiotensin II receptor (type AT1) antagonist.. Monitor for transient hypotension in volume/salt-depleted patients. INDICATIONS Treating high blood pressure alone or with other medicines. if hypotension occurs. adrenal glands).

or by things such as certain medical conditions or treatments. Hypromellose Eye Drops Hydromoor eye drops contain the active ingredient hypromellose. Hypromellose eye drops are also available without a brand name. prolonged use of computer screens (where you tend to blink less and thus not lubricate the eyes sufficiently). or drying atmospheric conditions such as air-conditioning. which is a type of medicine known as an eye lubricant. It produces a transparent.possible. These may be caused by your eye not producing enough tears to keep the eye moist. central heating or atmospheric pollution. Hypromellose eye drops provide soothing relief from the symptoms of dry eyes.) Hypromellose is a synthetic polymer that forms a film on the surface of the eye (cornea). Lab tests: Periodically monitor BUN and creatinine. such as soreness. and CBC with differential. (NB. lubricating and moistening film on the surface of the eye and is used as artificial tears. serum potassium. . ie as the generic medicine. liver enzymes. irritation or a gritty sensation.

do not confuse oxycodone with OxyContin. most effective in relieving acute pain. sweating. light-headedness. dry mouth. take only as directed. mechanism is believed to involve decreased permeability of cell membrane to Na. nausea & vomiting. sedation. which results in diminished transmission of pain impulses and analgesia. assess for drug seeking behaviors. itching. may take with . causes mild sedation and no antitussive effect.GENERIC NAME: OXYCODONE AND ACETOMINOPHEN CLASSIFICATION: Analgesic ACTION: Semi synthetic opiate that combines with specific receptors located in CNS to produce various effects. constipation NURSING CONSIDERATIONS: Combination drug. does not cause any anticoagulant effect or ulceration of GI tract INDICATIONS: Relief of moderate to moderately severe pain ADVERSE REACTIONS: Dizziness. do not confuse Percocet and Percodan.

including cisplatin. pruritus. gynecological disorder. pyrexia. prevent N&V associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. headache. or daily fractions to the abdomen ADVERSE REACTIONS: Diarrhea. to decrease GI upset. Ondansetron. avoid alcohol and any other CNS depressants without provider approval. constipation. may cause constipation. dizziness. a 5-HT3 antagonist. hypotension. and physical dependence. blocks this effect of serotonin. drowsiness/ sedation. the released serotonin may stimulate the vagal afferent nerves through the 5-HT3 receptors. drug may cause dizziness and drowsiness. rash/itching. single high-dose fraction to the abdomen. keep in safe place. greater than 50 mg/m2. anxiety/agitation. do not share drugs. hypoxia. shivers . Prevent N&V associated with radiotherapy in clients receiving either total body irradiation. urinary retention. malaise/fatigue. nausea& vomiting. thus stimulating the vomiting reflex. whether the drug acts centrally and/or peripherally to antagonize the effect of serotonin is not known INDICATIONS: Prevent N&V resulting from initial and repeated courses of cancer chemotherapy. tolerance may occur ONDANSETRON HYDROCHLORIDE CLASSIFICATION: Antiemetic ACTION: Cytotoxic chemotherapy is thought to release serotonin from enterochromaffin cells of the small intestine.

Treatment of glucocorticoid-induced osteoporosis. or Zosyn. Paget's disease. myalgias. constipation. hypophosphatemia. however. It does. abdominal pain. do not exceed 8 mg PO or 8 mg IV daily with impaired hepatic function. diarrhea. do not perform activities that require mental alertness until drug effects realized. diarrhea. nausea. vomiting. Food: Calcium and food (especially dairy products) reduce alendronate absorption. Zantac. may cause drowsiness or dizziness. 2 mg/mL Ondansetron injection requires no dilution for administration for postop N&V. localize preferentially to resorption sites of active bone turnover and has minimal to no interference with bone mineralization. to be given exactly as prescribed. report any rash. headache. dyspepsia. rash. INDICATIONS: Prevention and treatment of osteoporosis in postmenopausal women.NURSING CONSIDERATIONS: Do not confuse Zofran with Zoloft. drug is to prevent N&V. . BONE METABOLISM ACTION: Alendronate is a bisphosphonate that inhibits osteoclast-mediated bone resorption. or loss of response ALENDRONATE CLASSIFICATION: BISPHOSPHONATE. GI: Esophageal irritation and ulceration. REGULATOR. constipation. Antiresorption mechanism is not fully understood. altered respirations (brochospasms). Other: Arthralgias. INTERACTIONS Drug: Ranitidine increases alendronate availability. ADVERSE REACTIONS Endocrine: Hypocalcemia. inspect visually for particulate matter and discoloration before administering. flatulence.

2 mEq/L). leg cramps. Diagnostic test: Bone density scan every 12–18 mo. Periodically monitor renal and liver functions. serum alkaline phosphatase. twitching.5 grams 1-3 times daily with or without meals. cardiac arrythmias. abnormalities. and serum electrolytes. normal serum calcium level is 9-10. antihyperphosphatemic – 5-13 grams daily in divided doses with meals .4 mg. smooth muscle hyperexcitability. Discontinue drug if the Clcr <35 mL/min. fasting and 24 h urinary calcium.55. NURSING CONSIDERATIONS: Lab tests: Monitor albumin-adjusted serum calcium.CONTRAINDICATIONS: Hypersensitivity to alendronate or other bisphosphonates.dL (4. serum phosphate. Antacid (including heartburn. skeletal muscle spasms. and acid indigestion). severe renal impairment (Clcr 35 mL/min).25-1. sour stomach. hypocalcemia. Hypocalcemia is characterized by muscular fibrillation. anithyperphosphatemic USUAL DOSAGE: Hypocalcemia/Nutritional supplement – 1. titanic spasms. muscles. GENERIC NAME: CALCIUM CARBONATE CLASSIFICATION: Calcium salt ACTION: Calcium is essential for maintaining normal function of nerves. mental depression. the skeletal system. lactation. pregnancy (category C). and permeability of cell membranes and capillaries. and anxiety states INDICATIONS: Mild hypocalcemia.

potassium. tinea corporis. noting clinical presentation. lack of desired response. monitor calcium levels and renal function. assess for renal or parathyroid disease. INDICATIONS: Dermal infections including tinea pedis. . supplements need vitamin D to facilitate absorption. tinea cruris. and keep all follow-up appointments to evaluate drug response CLOTRIMAZOLE CLASSIFICATION: ANTIINFECTIVE. cancer clients with bone metastases. hypercalcemia NURSING CONSIDERATIONS: Perform thorough nursing history. also vulvovaginal and oropharyngeal candidiasis. ANTIFUNGAL ACTION: Has broad-spectrum fungicidal activity. ANTIBIOTIC. and other essential intracellular constituents with consequent loss of ability to replicate. indications for therapy. list drugs prescribed. ventricular fibrillation. renal calculi. headache. hypophosphatemia.ADVERSE REACTIONS: After PO use – GI irritation. permitting loss of phosphorous compounds. mild hypercalcemia (anorexia. constipation. especially if receiving digitalis products (may be contraindicated). note bone density findings. report adverse side effects. tinea versicolor. and any precipitating causes. sarcoidosis. Acts by altering fungal cell membrane permeability. renal or cardiac disease. N&V) CONTRAINDICATIONS: Digitalized clients.

systemic mycoses.  Anticipate signs of clinical improvement within the first week of drug use. cystitis. category B for topical preparations). vesication. mild urinary frequency. occasional nausea and vomiting (with oral troche). pruritus. desquamation. Report any signs of skin irritation with dermal preparations. vulval erythema and itching. skin fissures. Urogenital: Mild burning sensation. GENERIC NAME: DOCUSATE SODIU . and in children <3 y not established NURSING CONSIDERATIONS:  Evaluate effectiveness of treatment. bloating. urethritis. Safe use during pregnancy (category C for oral troches. edema. lactation. CONTRAINDICATIONS: Ophthalmic uses.ADVERSE REACTIONS GI: Abnormal liver function tests. erythema. Skin: Stinging. urticaria. lower abdominal cramps. pain and vaginal soreness during intercourse INTERACTIONS Drug: Intravaginal preparations may inactivate SPERMICIDES.

flatulence. electrolyte balance disturbance due to dehydration INTERACTIONS: May ↑ absorption of mineral oil from GI tract.CLASSIFICATION: Laxative. hard stools ROUTES OF ADMINISTRATION: Capsules. Constipation associated with dry. abdominal pain. Emollient ACTION: Acts by lowering the surface tension of feces and promoting penetration by water and fat (increases softness of fecal mass. rule out other intestinal disorders/obstruction where laxatives should not be used . may take 1-3 days to soften fecal matter due to minimally absorbing docusate salts. enteritis. note length of time ittakes for laxative to take effect. intestinal obstruction. note location. diet. dehydration. perianal irritation. diverticulitis. severe abdominal pain due to appendicitis. undiagnosed abdominal pain NURSING CONSIDERATIONS: Drink glass of water with each dose. assess activity levels. megacolon or bedridden patients. nausea & vomiting. have client identify habits and BM activities. exercise routines. triggers. 3-6 y/o: 20-60 mg. ulcerative colitis. cramps. type of discomfort. 6-12 y/o: 40-120 mg ADVERSE REACTIONS: Diarrhea. fecal impaction. Tablets USUAL DOSAGE: Adults and persons above 12 y/o: 50-500 mg. Oral Liquid. Syrup. intestinal obstruction. water intake. may take oralsolutions with milk or juice to help mask taste. Soft-Gel Capsules. not absorbed systematically. vomiting. CONTRAINDICATIONS: Nausea. does not seem to interfere with absorption of nutrients INDICATIONS: Lessens strain of defecation in persons with hernia or CV diseases or other diseases in which stool straining should be avoided. with abdominal pain and discomfort. Under 3y/o: 10-40mg.

heat cramps. irritability. Hematologic: Hyperkalemia. maintenance of normal kidney function. mental confusion. listlessness. Plays a prominent role in both formation and correction of imbalances in acid–base metabolism. INDICATIONS: To prevent and treat potassium deficit secondary to diuretic or corticosteroid therapy. Effective in the treatment of hypokalemic alkalosis (chloride. adynamic ileus. Lab test: Frequent serum electrolytes are . flaccid paralysis. not the gluconate). ECG changes in hyperkalemia: INTERACTIONS Drug: POTASSIUM-SPARING DIURETICS. essential for maintenance of intracellular isotonicity. altered sensitivity to digitalis glycosides. digitalis intoxication with AV conduction disturbance. and for enzyme activity. bradycardia. or arrest. Body as a Whole: Pain. anuria. diabetic acidosis. Respiratory: Respiratory distress. transmission of nerve impulses. untreated Addison's disease. ADVERSE REACTIONS: GI: Nausea. CV: Hypotension. NURSING CONSIDERATIONS: Monitor I&O ratio and pattern in patients receiving the parenteral drug. or malabsorption. stop infusion promptly and notify physician. patients receiving potassium-sparing diuretics. REPLACEMENT SOLUTION ACTION: Principal intracellular cation. paresthesias of extremities. Also indicated when potassium is depleted by severe vomiting. ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS may cause hyperkalemia. muscle weakness and heaviness of limbs. Urogenital: Oliguria. arrhythmias. acute dehydration. diarrhea. CONTRAINDICATIONS: Severe renal impairment. crush syndrome. diarrhea. If oliguria occurs. fistulas.GENERIC NAME: POTASSIUM CHLORIDE CLASSIFICATION: ELECTROLYTIC AND WATER BALANCE AGENT. and smooth muscles. difficulty in swallowing. skeletal. intestinal drainage. early postoperative oliguria (except during GI drainage). vomiting. contraction of cardiac. hyperkalemia. abdominal distension. cardiac depression. prolonged diuresis. severe hemolytic reactions.

. may result from any therapeutic dosage. and the patient may be asymptomatic. Appendix F).Monitor for and report signs of GI ulceration (esophageal or epigastric pain or hematemesis).warranted. Irregular heartbeat is usually the earliest clinical indication of hyperkalemia. see S&S.Monitor patients receiving parenteral potassium closely with cardiac monitor.Be alert for potassium intoxication (hyperkalemia.